News Focus
News Focus
icon url

baltimorebullet

03/18/19 9:45 AM

#185611 RE: McMagyar #185609

This question has been answered up front.

"All patients who participate in the study will be eligible to receive ANAVEX(R)2-73 under a voluntary open label extension protocol."

BB
icon url

XenaLives

03/18/19 9:53 AM

#185615 RE: McMagyar #185609

I think that is a reasonable scenario. Rett Organization should also get the same benefit. Rewarding non profits with an endowment of preferred shares would encourage more such participation.

It would make a great PR and development plan for Anavex.

icon url

ExtremelyBullishZig

03/18/19 12:26 PM

#185650 RE: McMagyar #185609

Neither of us is right or wrong...as you said these are just our ideas. I look forward to seeing how this all plays out.